Article
Sertraline for the treatment of depression in Alzheimer disease: genetic influences.
Journal of geriatric psychiatry and neurology - 1 Dec 2011
Peters Matthew E, Vaidya Vijay, Drye Lea T, Rosenberg Paul B, Martin Barbara K, Porsteinsson Anton P, Frangakis Constantine E, Mintzer Jacobo, Weintraub Daniel, Schneider Lon S, Rabins Peter V, Munro Cynthia A, Meinert Curtis L, Lyketsos Constantine G, Avramopoulos Dimitri, Dimitri Avramopoulos
Abstract excerpt
OBJECTIVE: To assess the potential for genetic influences on sertraline treatment efficacy for depression of Alzheimer disease (dAD). Four functional genetic variants were studied: 2 serotonin receptors (HTR2A-T102C and HTR2C-Cys23Ser), the serotonin transporter (5HTT-LPR), and brain-derived neurotrophic factor (BDNF-Val66Met). Treatment response by genotype was measured by (1) the modified Alzheimer's Disease...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
